Excellent
Mostly Aligned
Patient Risk:
Low
Summary
The AI statements provided are largely accurate but are not supported by the supplied FDA label excerpts (which focus on boxed warning risks from benzodiazepines/CNS depressants). Claims about inactive ingredients and excipient-related considerations are unsupported by the provided label text.
Category Scores
Accurate Statements
The excerpts provided match hydrocodone bitartrate and acetaminophen tablets labeling (including tablet strengths and REMS language).
Supported in the user-provided context that the excerpts provided match hydrocodone bitartrate and acetaminophen tablets labeling; however, the provided evaluation content does not quote REMS language beyond the boxed warning header.
Unsupported Statements
Norco tablets contain hydrocodone/acetaminophen.
Not supported by the supplied label excerpts provided in the prompt (the excerpts supplied only support warnings/contraindication elements for hydrocodone bitartrate and acetaminophen tablets, not explicitly that Norco tablets contain this combination).
The inactive ingredients in Norco can vary by manufacturer and formulation strength.
No inactive-ingredient or excipient/manufacturer-variation content is included in the provided prescribing-information excerpts.
The inactive-ingredient list for Norco is available in the package insert or the FDA label for the specific strength and manufacturer.
Not supported by the provided excerpts.
Inactive ingredients can matter for allergies to specific excipients.
Not supported by the provided excerpts.
Inactive ingredients can matter for sensitivities to excipients.
Not supported by the provided excerpts.
Inactive ingredients can matter for dietary restrictions or religious considerations related to excipients.
Not supported by the provided excerpts.
Inactive ingredients can differ between liquid hydrocodone formulations and Norco tablets.
Not supported by the provided excerpts.
Liquid formulations and extended-release products use different excipients than tablets.
Not supported by the provided excerpts.
Norco is a hydrocodone/acetaminophen tablet brand.
Not supported by the provided label excerpts.
Contradictions
Important Omissions
No evaluation of boxed warnings/Warnings and Precautions content about concomitant use with benzodiazepines/CNS depressants was explicitly stated in the initial claim list (the list focuses on excipients).
Importance:
Low
Safety Assessment
Potential Patient Risk:
Low
The only clearly label-supported content in the prompt pertains to opioid + benzodiazepine/CNS depressant risks; the additional excipient-related claims are unsupported by the supplied excerpts. No direct unsafe dosing or contraindication misuse is claimed.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Mostly Aligned
Primary Issue
Several claims about Norco and inactive ingredients are not supported by the provided prescribing-information excerpts.
Suggested Improvement
Limit claims to content directly quoted or supported by the supplied label excerpts (e.g., concomitant use with benzodiazepines/CNS depressants, associated risks, and monitoring guidance). If discussing excipients, provide label text that explicitly addresses inactive ingredients.